BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30393160)

  • 1. Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-β and TRAIL and suppress the growth of H460 human lung cancer cells.
    Jung PY; Ryu H; Rhee KJ; Hwang S; Lee CG; Gwon SY; Kim J; Kim J; Yoo BS; Baik SK; Bae KS; Eom YW
    Cancer Lett; 2019 Jan; 440-441():202-210. PubMed ID: 30393160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAIL-overexpressing Adipose Tissue-derived Mesenchymal Stem Cells Efficiently Inhibit Tumor Growth in an H460 Xenograft Model.
    Un Choi Y; Yoon Y; Jung PY; Hwang S; Hong JE; Kim WS; Sohn JH; Rhee KJ; Bae KS; Eom YW
    Cancer Genomics Proteomics; 2021; 18(4):569-578. PubMed ID: 34183389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose Tissue-Derived Mesenchymal Stem Cells Suppress Growth of Huh7 Hepatocellular Carcinoma Cells via Interferon (IFN)-β-Mediated JAK/STAT1 Pathway
    Byun CS; Hwang S; Woo SH; Kim MY; Lee JS; Lee JI; Kong JH; Bae KS; Park IH; Kim SH; Eom YW
    Int J Med Sci; 2020; 17(5):609-619. PubMed ID: 32210710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand.
    Du J; Zhou L; Chen X; Yan S; Ke M; Lu X; Wang Z; Yu W; Xiang AP
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1305-14. PubMed ID: 22554587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin-7 suppresses the cytotoxicity of TRAIL-expressing mesenchymal stem cells in H460 human non-small cell lung cancer cells.
    Xia P; Wang W; Bai Y
    Apoptosis; 2014 Mar; 19(3):491-505. PubMed ID: 24242915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β.
    Yoon N; Park MS; Shigemoto T; Peltier G; Lee RH
    Cell Death Dis; 2016 Apr; 7(4):e2191. PubMed ID: 27077807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.
    Wang Y; He L; He G; Kong Y; Liu X; Cai H; Liu X; Tan W
    Sheng Wu Gong Cheng Xue Bao; 2010 Jun; 26(6):780-8. PubMed ID: 20815258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-γ-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway.
    Yang X; Du J; Xu X; Xu C; Song W
    J Immunol Res; 2014; 2014():318098. PubMed ID: 24971369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-binding Cell-penetrating Peptide-based TRAIL Over-expression in Adipose Tissue-derived Mesenchymal Stem Cells Inhibits Glioma U251MG Growth.
    Shin J; Baik SK; Yoon Y; Hwang S; Sohn JH; Jo M; Kim WS; Rhee KJ; Whang K; Eom YW
    Anticancer Res; 2021 Jun; 41(6):2859-2866. PubMed ID: 34083276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochalasin B-induced membrane vesicles from human mesenchymal stem cells overexpressing TRAIL, PTEN and IFN-β1 can kill carcinoma cancer cells.
    Chulpanova DS; Gilazieva ZE; Akhmetzyanova ER; Kletukhina SK; Rizvanov AA; Solovyeva VV
    Tissue Cell; 2021 Dec; 73():101664. PubMed ID: 34678531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-β and suppress the growth of MCF-7 human breast cancer cells.
    Ryu H; Oh JE; Rhee KJ; Baik SK; Kim J; Kang SJ; Sohn JH; Choi E; Shin HC; Kim YM; Kim HS; Bae KS; Eom YW
    Cancer Lett; 2014 Oct; 352(2):220-7. PubMed ID: 25016057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M1 Macrophages Promote TRAIL Expression in Adipose Tissue-Derived Stem Cells, Which Suppresses Colitis-Associated Colon Cancer by Increasing Apoptosis of CD133
    Eom YW; Akter R; Li W; Lee S; Hwang S; Kim J; Cho MY
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical models.
    Guiho R; Biteau K; Grisendi G; Chatelais M; Brion R; Taurelle J; Renault S; Heymann D; Dominici M; Redini F
    Cytotherapy; 2018 Aug; 20(8):1037-1045. PubMed ID: 30093324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
    Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
    Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.
    Lathrop MJ; Sage EK; Macura SL; Brooks EM; Cruz F; Bonenfant NR; Sokocevic D; MacPherson MB; Beuschel SL; Dunaway CW; Shukla A; Janes SM; Steele C; Mossman BT; Weiss DJ
    Cancer Gene Ther; 2015 Jan; 22(1):44-54. PubMed ID: 25525034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.
    Ciavarella S; Grisendi G; Dominici M; Tucci M; Brunetti O; Dammacco F; Silvestris F
    Br J Haematol; 2012 Jun; 157(5):586-98. PubMed ID: 22420897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal Stem Cells Combined With IFNγ Induce Apoptosis of Breast Cancer Cells Partially Through TRAIL.
    Yenilmez EN; Genc D; Farooqi AA; Tunoglu S; Zeybek U; Akkoc T; Yaylim İ
    Anticancer Res; 2020 Oct; 40(10):5641-5647. PubMed ID: 32988888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy.
    Grisendi G; Bussolari R; Cafarelli L; Petak I; Rasini V; Veronesi E; De Santis G; Spano C; Tagliazzucchi M; Barti-Juhasz H; Scarabelli L; Bambi F; Frassoldati A; Rossi G; Casali C; Morandi U; Horwitz EM; Paolucci P; Conte P; Dominici M
    Cancer Res; 2010 May; 70(9):3718-29. PubMed ID: 20388793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.